跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TAPENTADOL RETARD STADA 50 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
TAPENTADOL RETARD STADA 50 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG
Approved
STANDARD
TAPENTADOL RETARD STADA 50 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG
Laboratorio Stada S.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Nov 17, 2022
Approval ID
18fe413682dbeb2f
Company
Laboratorio Stada S.L.
Type
Standard
Approval Details
Approval Id
18fe413682dbeb2f
Drug Cima Aemps Name
TAPENTADOL RETARD STADA 50 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG
Register Number
88293
Holder Company Name
Laboratorio Stada S.L.
Marketing Company Name
Laboratorio Stada S.L.
Authorization Date
2022-11-17
Dosage Form
COMPRIMIDO DE LIBERACIÓN PROLONGADA
Dose
50 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica. Estupefacientes
Commercialized
Yes
Company Name
Laboratorio Stada S.L.
Active Ingredients
TAPENTADOL FOSFATO
76,57 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Nov 17, 2022
Approval ID
18fe413682dbeb2f
Type
Standard
Back to CIMA-AEMPS Approvals